This event has passed.

Clinical trial of pemigatinib, atezolizumab, and bevacizumab for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement

Name: Clinical trial of pemigatinib, atezolizumab, and bevacizumab for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement
Start: 2025-02-13T16:00:00-05:00
End: 2025-02-13T17:00:00-05:00

February 13 @ 4:00 pm - 5:00 pm

Details

Date:: February 13
Time:: 4:00 pm - 5:00 pm
Event Category:: Webinar
Website:: https://cholangiocarcinoma-org.zoom.us/webinar/register/WN_V_Wa2Y4vT0um9UWrJw5koA